20 reports

HIV STAT-PAK®AND SURE CHECK®HIV BUSINESS, AFTER WE REGAINED THE U. S.

  • Clinical Chemistry
  • North America
  • Forecast
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • THERAPEUTIC DRUG MONITORING (TDM) TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • 6.2 CLINICAL CHEMISTRY TESTING

IN 2014, ~##, ## PEOPLE WERE SUFFERING FROM AIDS IN THE UK.

  • Clinical Chemistry
  • Laboratory
  • World
  • Forecast
  • Quest Diagnostics Incorporated

HIV STAT-PAK®AND SURE CHECK®HIV BUSINESS, AFTER WE REGAINED THE U. S.

  • Clinical Chemistry
  • Healthcare
  • North America
  • United States
  • Thermo Fisher Scientific, Inc.

HIV/ AIDS and cervical cancer.

  • Clinical Chemistry
  • Clinical Trial
  • Diagnostics
  • Laboratory
  • GlobalData's company

Viral load testing is critical to providing appropriate treatment for HIV positive adults and also identifying infants who may be HIV positive.

  • Clinical Chemistry
  • Medical Device
  • Europe
  • France
  • bioMerieux S.A.

ABL OFFERS DISEASE-SPECIFIC DRUG RESISTANCE DATA INTERPRETATION FOR HIV, HEPATITIS B AND HEPATITIS C.

  • Clinical Chemistry
  • Medical Device
  • Australia
  • Oceania
  • bioMerieux S.A.

ABL offers disease-specific drug resistance data interpretation for HIV, Hepatitis B and Hepatitis C.

  • Clinical Chemistry
  • In Vitro Diagnostics
  • Brazil
  • South America
  • bioMerieux S.A.

ABL offers disease-specific drug resistance data interpretation for HIV, Hepatitis B and Hepatitis C.

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Europe
  • Spain
  • bioMerieux S.A.

ABL offers disease-specific drug resistance data interpretation for HIV, Hepatitis B and Hepatitis C.

  • Clinical Chemistry
  • Medical Device
  • Mexico
  • North America
  • bioMerieux S.A.

ABL offers disease-specific drug resistance data interpretation for HIV, Hepatitis B and Hepatitis C.

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Europe
  • Russian Federation
  • bioMerieux S.A.

ABL offers disease-specific drug resistance data interpretation for HIV, Hepatitis B and Hepatitis C.

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Asia
  • China
  • bioMerieux S.A.

ABL OFFERS DISEASE-SPECIFIC DRUG RESISTANCE DATA INTERPRETATION FOR HIV, HEPATITIS B AND HEPATITIS C.

  • Clinical Chemistry
  • Healthcare
  • Asia
  • Japan
  • Sosei Group Corporation

ABL offers disease-specific drug resistance data interpretation for HIV, Hepatitis B and Hepatitis C.

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Asia
  • India
  • Tosoh Corporation

LIAISON XL murex HIV Ab/ Ag high throughput (HT)##: new test for the " blood banks" line on LIAISON XL.

  • Clinical Chemistry
  • Medical Device
  • Europe
  • Italy
  • Curetis N.V.

ABL offers disease-specific drug resistance data interpretation for HIV, Hepatitis B and Hepatitis C.

  • Clinical Chemistry
  • Medical Device
  • Asia
  • South Korea
  • bioMerieux S.A.

ABL OFFERS DISEASE-SPECIFIC DRUG RESISTANCE DATA INTERPRETATION FOR HIV, HEPATITIS B AND HEPATITIS C.

  • Clinical Chemistry
  • Healthcare
  • Europe
  • Germany
  • QIAGEN N.V.

NAT comments: Deborah Gold, chief executive of NAT (National AIDS Trust), said: " We currently have a long way to go when it comes to diagnosing people with HIV on time.

  • Clinical Chemistry
  • Healthcare
  • Europe
  • United Kingdom
  • GE Healthcare Limited

ABL OFFERS DISEASE-SPECIFIC DRUG RESISTANCE DATA INTERPRETATION FOR HIV, HEPATITIS B AND HEPATITIS C.

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Canada
  • North America
  • Miraculins Inc.

Their target therapeutics area is rheumatoid arthritis, HIV/ AIDS, respiratory infections, cancer, diabetes, men' s and women' s health, and genetic conditions.

  • Clinical Chemistry
  • North America
  • United States
  • Forecast
  • Ortho-Clinical Diagnostics, Inc.

THE RESEARCH WILL FOCUS ON FURTHER DEVELOPMENT OF DIAGNOSTIC TESTS TO DETERMINE HIV DRUG RESISTANCE FOR USE IN CLINICAL MANAGEMENT OF HIV POSITIVE PATIENTS.

  • Clinical Chemistry
  • Private Placement
  • North America
  • United States
  • Illumina, Inc.